BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation

Blood

Volumn 113, Issue 17, 2009, Pages 3969-3977

  Eckl Dorna, Julia ^a   Batista, Facundo D ^a  

^a THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; ANTIGEN CPG; B LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; LYSOZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONJUGATION; CONTROLLED STUDY; DENDRITIC CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IN VIVO STUDY; MACROPINOCYTOSIS; MOUSE; NONHUMAN; PINOCYTOSIS; PLASMA CELL; PRIORITY JOURNAL; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ANIMAL; ANTIBODY SPECIFICITY; C57BL MOUSE; CELL CULTURE; CELL LINEAGE; CHICKEN; CPG ISLAND; CYTOLOGY; GENE REARRANGEMENT; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOPOIESIS; METABOLISM;

ANIMALS; ANTIBODY SPECIFICITY; ANTIGENS; B-LYMPHOCYTES; CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; CHICKENS; CPG ISLANDS; IMMUNIZATION; IMMUNOGLOBULIN CLASS SWITCHING; LIGANDS; LYMPHOCYTE ACTIVATION; LYMPHOPOIESIS; MICE; MICE, INBRED C57BL; MURAMIDASE; RECEPTORS, ANTIGEN, B-CELL; TOLL-LIKE RECEPTOR 9;

EID: 65449118056     PISSN: 00064971     EISSN: 15280020     Source Type: None    
DOI: 10.1182/blood-2008-10-185421     Document Type: Article

References (54)

1. MacLennan I, Toellner K, Cunningham A, et al. Extrafollicular antibody responses. Immunol Rev. 2003;194:8-18.
2. MacLennan IC. Germinal centers. Annu Rev Immunol. 1994;12:117-139.
3. Moller G. Role of somatic mutation in the generation of lymphocyte diversity. Immunol Rev. 1987;96:1-162.
4. Rajewsky K. Clonal selection and learning in the antibody system. Nature. 1996;381:751-758. (Pubitemid 26243107)
5. Paus D, Phan T, Chan T, Gardam S, Basten A, Brink R. Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J Exp Med. 2006;203:1081-1091.
6. Batista F, Neuberger M. Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate. Immunity. 1998;8:751-759. (Pubitemid 28294522)
7. Guermonprez P, England P, Bedouelle H, Leclerc C. The rate of dissociation between antibody and antigen determines the efficiency of antibody-mediated antigen presentation to T cells. J Immunol. 1998;161:4542-4548. (Pubitemid 28492025)
8. Kouskoff V, Famiglietti S, Lacaud G, et al. Antigens varying in affinity for the B cell receptor induce differential B lymphocyte responses. J Exp Med. 1998;188:1453-1464. (Pubitemid 28489582)
9. Shih T, Roederer M, Nussenzweig M. Role of antigen receptor affinity in T cell-independent antibody responses in vivo. Nat Immunol. 2002;3:399-406. (Pubitemid 34308629)
10. Reth M. Antigen receptor tail clue. Nature. 1989;338:383-384.
11. Reth M, Wienands J. Initiation and processing of signals from the B cell antigen receptor. Annu Rev Immunol. 1997;15:453-479. (Pubitemid 27169289)
12. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature. 1985;314:537-539.
13. Rock K, Benacerraf B, Abbas A. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J Exp Med. 1984;160:1102-1113.
14. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335-376.
15. Krieg A, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev. 2007;220:251-269.
16. Bourke E, Bosisio D, Golay J, Polentarutti N, Mantovani A. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood. 2003;102:956-963. (Pubitemid 36917790)
17. Busconi L, Bauer J, Tumang J, et al. Functional outcome of B cell activation by chromatin immune complex engagement of the B cell receptor and TLR9. J Immunol. 2007;179:7397-7405.
18. Latz E, Schoenemeyer A, Visintin A, et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol. 2004;5:190-198. (Pubitemid 38208361)
19. Leifer CA, Kennedy MN, Mazzoni A, Lee C, Kruhlak MJ, Segal DM. TLR9 is localized in the endoplasmic reticulum prior to stimulation. J Immunol. 2004;173:1179-1183. (Pubitemid 38924294)
20. Chaturvedi A, Dorward D, Pierce S. The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity. 2008;28:799-809.
21. Ewald SE, Lee BL, Lau L, et al. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature. 2008;456:658-662.
22. Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature. 2000;408:740-745. (Pubitemid 32015992)
23. Krieg A, Yi A, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 1995;374:546-549.
24. Leadbetter E, Rifkin I, Hohlbaum A, Beaudette B, Shlomchik M, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 2002;416:603-607. (Pubitemid 34406754)
25. Viglianti G, Lau C, Hanley T, Miko B, Shlomchik M, Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity. 2003;19:837-847. (Pubitemid 37542304)
26. Christensen S, Kashgarian M, Alexopoulou L, Flavell R, Akira S, Shlomchik M. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med. 2005;202:321-331. (Pubitemid 41043827)
27. Ehlers M, Fukuyama H, McGaha T, Aderem A, Ravetch J. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med. 2006;203:553-561.
28. Herlands R, William J, Hershberg U, Shlomchik M. Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites. Eur J Immunol. 2007;37:3339-3351.
29. Jegerlehner A, Maurer P, Bessa J, Hinton H, Kopf M, Bachmann M. TLR9 signaling in B cells determines class switch recombination to IgG2a. J Immunol. 2007;178:2415-2420. (Pubitemid 46233441)
30. Jiang W, Lederman M, Harding C, Rodriguez B, Mohner R, Sieg S. TLR9 stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function. Eur J Immunol. 2007;37:2205-2213. (Pubitemid 47250213)
31. Ruprecht C, Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol. 2006;36:810-816.
32. Gavin AL, Hoebe K, Duong B, et al. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science. 2006;314:1936-1938. (Pubitemid 46026117)
33. Pasare C, Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature. 2005;438:364-368. (Pubitemid 41643953)
34. Häcker H, Mischak H, Miethke T, et al. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 1998;17:6230-6240. (Pubitemid 28497796)
35. Fleire S, Goldman J, Carrasco Y, Weber M, Bray D, Batista F. B cell ligand discrimination through a spreading and contraction response. Science. 2006;312:738-741.
36. Barral P, Eckl-Dorna J, Harwood N, et al. B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo. Proc Natl Acad Sci U S A. 2008;105:8345-8350. (Pubitemid 351904758)
37. Adachi O, Kawai T, Takeda K, et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 1998;9:143-150. (Pubitemid 28361303)
38. Allen CD, Okada T, Tang HL, Cyster JG. Imaging of germinal center selection events during affinity maturation. Science. 2007;315:528-531. (Pubitemid 46175759)
39. Teh YM, Neuberger MS. The immunoglobulin (Ig)alpha and Igbeta cytoplasmic domains are independently sufficient to signal B cell maturation and activation in transgenic mice. J Exp Med. 1997;185:1753-1758.
40. Phan TG, Amesbury M, Gardam S, et al. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J Exp Med. 2003;197:845-860. (Pubitemid 36437862)
41. Nimmerjahn F, Ravetch J. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science. 2005;310:1510-1512.
42. Goodnow CC, Crosbie J, Adelstein S, et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature. 1988;334:676-682. (Pubitemid 18197565)
43. Song W, Cho H, Cheng P, Pierce SK. Entry of B cell antigen receptor and antigen into class II peptide-loading compartment is independent of receptor cross-linking. J Immunol. 1995;155:4255-4263.
44. Hou B, Reizis B, Defranco AL. Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms. Immunity. 2008;29:272-282.
45. Blink EJ, Light A, Kallies A, Nutt SL, Hodgkin PD, Tarlinton DM. Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization. J Exp Med. 2005;201:545-554. (Pubitemid 40289545)
46. Dal Porto JM, Haberman AM, Shlomchik MJ, Kelsoe G. Antigen drives very low affinity B cells to become plasmacytes and enter germinal centers. J Immunol. 1998;161:5373-5381. (Pubitemid 28519098)
47. O'Connor B, Vogel L, Zhang W, et al. Imprinting the fate of antigen-reactive B cells through the affinity of the B cell receptor. J Immunol. 2006;177:7723-7732. (Pubitemid 44846288)
48. Herlands RA, Christensen SR, Sweet RA, Hershberg U, Shlomchik MJ. T cell-independent and Toll-like receptor-dependent antigen-driven activation of autoreactive B cells. Immunity. 2008;29:249-260.
49. Siemasko K, Eisfelder BJ, Williamson E, Kabak S, Clark MR. Cutting edge: signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes. J Immunol. 1998;160:5203-5208. (Pubitemid 28267803)
50. Amigorena S, Drake JR, Webster P, Mellman I. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature. 1994;369:113-120. (Pubitemid 24153433)
51. Watts C. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat Immunol. 2004;5:685-692. (Pubitemid 39023297)
52. Moody DB, Porcelli SA. Intracellular pathways of CD1 antigen presentation. Nat Rev Immunol. 2003;3:11-22.
53. Heikenwalder M, Polymenidou M, Junt T, et al. Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med. 2004;10:187-192. (Pubitemid 38524890)
54. Traggiai E, Becker S, Subbarao K, et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med. 2004;10:871-875. (Pubitemid 39070862)